FREQUENTLY ASKED QUESTIONS. Frequently Asked Questions: Table of Contents How can neuropathic pain be identified? What is the best non-pharmacological.

Slides:



Advertisements
Similar presentations
Pain Management in Primary Care Kimberly Zoberi, MD Saint Louis University School of Medicine.
Advertisements

Non-Opiate Pain Relievers David A. Cooke, MD, FACP Assistant Professor, Department of Internal Medicine University of Michigan Health System.
Neuropathic pain in cancer patients
1 Pain. 2 Types of Pain Acute Pain Acute Pain –Complex combination of sensory, perceptual, & emotional experiences as a result of a noxious stimulus –Mediated.
Neuropathic Pain in Advanced Illness Russell K. Portenoy, MD Chairman and Gerald J. and Dorothy R. Friedman Chair in Pain Medicine and Palliative Care.
Neuropathic Pain in Serious Medical Illness Russell K. Portenoy, MD Chairman and Gerald J. Chair in Pain Medicine and Palliative Care Department of Pain.
1. Development Committee Mario H. Cardiel, MD, MSc Rheumatologist Morelia, Mexico Andrei Danilov, MD, DSc Neurologist Moscow, Russia Smail Daoudi, MD.
Assessment and diagnosis
ASSESSMENT AND DIAGNOSIS. Overview Diagnosing Neuropathic Pain Is Challenging Harden N, Cohen M. J Pain Symptom Manage 2003; 25(5 Suppl):S12-7; Woolf.
Development Committee
CLINICAL CASES. Case: Mr. LBP Mr. LBP: Case Presentation Mr. LBP is a 35-year-old male He fell down while participating in a recreational sports activity.
FREQUENTLY ASKED QUESTIONS. Frequently Asked Questions Why is it important to understand the mechanisms of inflammation in joint diseases? Is joint pain.
Pathophysiology.
Frequently asked questions
INTERACTIVE QUESTIONS. Discussion Question How long does it take most of your patients to recover from low back pain? Pathophysiology.
CLINICAL CASES. Case Template Patient Profile Gender: male/female Age: # years Occupation: Enter occupation Current symptoms: Describe current symptoms.
Canadian Diabetes Association Clinical Practice Guidelines Neuropathy Chapter 31 Vera Bril, Bruce Perkins, Cory Toth.
Pharmacotherapy for Chronic Pain
 CASE  LBP caused by OA  PAIN PATHWAY  PAIN SENSITIZATION  PAIN MANAGEMENT  Role of Pain Medications in the Pain Pathway  Prevention.
Pharmacologic Treatment of Post-Herpetic Neuralgia (PHN)
Depression Ibrahim Sales, Pharm.D. Associate Professor of Clinical Pharmacy King Saud University
Copyright © 2015 Cengage Learning® 1 Chapter 19 Analgesics, Sedatives, and Hypnotics.
NEUROPATHIC PAIN – OPTIMIZING PATIENT OUTCOME WITH COMBINATION THERAPY.
Spinal Cord Stimulators in Neuropathic Pain. Introduction Chronic pain is very common Immense physical, psychological, societal impact Financial burden.
Cancer and Neuropathic Pain Mike Bennett Professor of Palliative Medicine Lancaster University.
Problem Solving in Persistent Pain Syndromes: a case-based approach Copyright © 2005 Thomson Professional Postgraduate Services ®. All rights reserved.
Treatment of Chronic Non-Cancer Pain Ross Bryan Mercer University MS III August 2012.
Treatment of neuropathic pain “Low technology treatment methods”
6th Annual EOOC/NSS Workers' Comp Seminar 2/26/ The Role of Adjuvant Medications in the Treatment of the Injured Worker Benjamin G Benner, MD, FACS.
Presented by Robert Dworkin, Ph.D. at the Anesthetic and Life Support Drugs Advisory Committee Meeting on May 16, 2002.
Gabapentin in the Treatment of Peripheral neuropathy
Pain management for AKT NICE guidelines: Neuropathic pain Opioid conversion Controlled drugs.
EFNS Guidelines on Neuropathic Pain Assessment Dr.ssa G Di Stefano Prof. G. Cruccu Dipartimento di Neurologia e Psichiatria, Università “Sapienza” di Roma.
AM Report 6/30/10 Justin Crocker PGY-3. Functional Abdominal Pain Chronic pain disorder that is not explainable by a structural or metabolic disorder.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Chronic pain Sai Yan Au. Chronic Pain  Definition  Causes and mechanisms of chronic pain  Effects of chronic pain  Assessment and evaluation  Management.
Strategies to Switch Antidepressants Brittany Parmentier, PharmD PGY2 Behavioral Care Resident Butler University/Community Health Network This speaker.
NEUROPATHIC PAIN Dr. Mike Bennett Senior Clinical Lecturer in Palliative Medicine St. Gemma's Hospice and University of Leeds.
Medications for Pain: What You Need to Know for Treatment in Workers’ Compensation Suzanne Novak, MD, PhD 5/17/07.
Health Care, Education and Researchwww.billingsclinic.com Maximizing Medications for Good Outcomes Lee H. Stringer, Pharm.D., BCPS, FASCP, CPE Clinical.
Pharmacotherapy of Pain: Adjuvant Analgesics. Adjuvant Analgesics Defined as drugs with other indications that may be analgesic in specific circumstances.
Diagnosis and Management of Diabetic Neuropathies Part 4
The Use Of Adjuvants In Pain Management Stewart W. Stein, M.D. Medical Director, Good Shepherd Hospice.
Katy Trinkley, PharmDAngie Thompson, PharmD.  Opioid risks and risk prevention strategies  Medication treatment by pain type  Fundamental principles.
Aging Q3 Pain Management ACOVE  Pharmacological treatment with analgesics for pain is the most common in the elderly, however, the use of alternative medications.
Opioids plus adjuvants for cancer pain: systematic review Mike Bennett Professor of Palliative Medicine Lancaster University, UK.
Adjuvants or Co-analgesics Disclaimer: This presentation contains information on the general principles of pain management. This presentation cannot account.
SCS and IDDS: Patient Selection
Jessica S. Merlin, MD, MBA Assistant Professor of Medicine University of Alabama at Birmingham Birmingham, Alabama Chronic Pain in Patients With HIV: What.
PATHOPHYSIOLOGY. Freynhagen R, Baron R. Curr Pain Headache Rep 2009; 13(3):185-90; Jensen TS et al. Pain 2011; 152(10):2204-5; Julius D et al. In: McMahon.
Dr. Rupak Sethuraman. SPECIFIC LEARNING OBJECTIVES Various management techniques of orofacial pain Management of common orofacial pain disorders.
Fibromyalgia Natalie Walker, PharmD PGY1 Resident, Lexington VAMC
Treating generalised anxiety disorder in primary care – an example of a treatment pathway Step 3: review and consideration of alternative treatments Step.
Pain Management Elizabeth Whiteman, M.D.. Goals and Objectives Pathophysiology of pain Classification of pain Assessment of pain Treatment ▫Analgesics.
CIPN: Considerations for Drug Development
List Three Mechanisms by which Chronic Opioid Therapy Can Worsen Pain
Section III: Pharmacological Therapies
Are you getting the best treatment for your low back pain?
Newer guidelines for treatment of neuropathic pain
Now What? Non-Opioid Alternatives for Pain
Common Functional Gastroenterological Disorders Associated With Abdominal Pain  Adil E. Bharucha, MBBS, MD, Subhankar Chakraborty, MBBS, PhD, Christopher.
Tricyclic and Tetracyclic Antidepressants Pharmacology and Indications
Class Medication Recommendatio n Starting dose Max dose Adequate Trial
PHARMACOTHERAPY - I PHCY 310
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles  M.R. Mulvey, E.G. Boland, D. Bouhassira,
Pathophysiology of Pain,Classification and Treatment
Neuropathic Pain: Principles of Diagnosis and Treatment
Neuropathic pain: from pathophysiology to treatment
Presentation transcript:

FREQUENTLY ASKED QUESTIONS

Frequently Asked Questions: Table of Contents How can neuropathic pain be identified? What is the best non-pharmacological treatment for neuropathic pain? What is the most effective way to relieve symptoms of allodynia? Why are NSAIDs not effective in neuropathic pain? What about surgery for neuropathic pain? When and why should combination therapy be used for neuropathic pain? How should medications for neuropathic pain be titrated? Can you use α 2 δ ligands with CCBs? Can you stop α 2 δ ligands “cold turkey”? CCB = calcium channel blocker; NSAID = non-steroidal anti-inflammatory drug

How can neuropathic pain be identified? Burning Tingling Shooting Electric shock-like Numbness Be alert for common verbal descriptors of neuropathic pain: Baron R et al. Lancet Neurol 2010; 9(8):807-19; Gilron I et al. CMAJ 2006; 175(3):

Neuropathic Pain Screening Tools LANSSDN4NPQpainDETECTID Pain Symptoms Pricking, tingling, pins and needlesxxxxX Electric shocks of shootingXxxxx Hot or burningXxxxx Numbnessxxxx Pain evoked by light touchingXxxx Painful cold or freezing painxX Clinical examination Brush allodyniaXX Raised soft touch thresholdX Altered pin prick thresholdXX DN4 = Douleur Neuropathique en 4 Questions (DN4) questionnaire; LANSS = Leeds Assessment of Neuropathic Symptoms and Signs; NPQ = Neuropathic Pain Questionnaire Bennett MI et al. Pain 2007; 127(3): ; Haanpää M et al. Pain 2011; 152(1): Neuropathic pain screening tools rely largely on common verbal descriptors of pain } } Some screening tools also include bedside neurological examination Select tool(s) based on ease of use and validation in the local language

DN4 Completed by physician in office Differentiates neuropathic from nociceptive pain 2 pain questions (7 items) 2 skin sensitivity tests (3 items) Score  4 is an indicator for neuropathic pain Validated DN4 = Douleur neuropathique en 4 questions Bouhassira D et al. Pain 2005; 114(1-2):29-36.

What is the best non-pharmacological treatment for neuropathic pain? CBT = cognitive behavioral therapy 1. Chetty S et al. S Afr Med J 2012; 102(5):312-25; 2. Bril V et al. Neurology 2011; 76(20): ; 3. Cruccu G et al. Eur J Neurol 2007; 14(9):952-70; 4. Pittler MH, Ernst E. Clin J Pain 2008; 24(8):731-35; 5. Dubinsky RM et al. Neurology 2004; 63(6):959-65; 6. Freynhagen R, Bennett MI. BMJ 2009; 339:b3002; 7. Morley S. Pain 2011;152(3 Suppl):S Physiotherapy 1 Alternative therapies and spiritual healing 1-4 Psychotherapy/CBT 6,7 Patient education 1 Various non-pharmacological treatment modalities are mentioned in guidelines, but no modality is universally recommended 1-5 Multimodal pain management programs 5,6 Various non-pharmacological treatments are available for neuropathic pain and may be discussed with patients. Treatments should be selected based on presumed safety, patient interest and availability.

Evidence for Non-pharmacological Therapies in Neuropathic Pain Studied therapies include: – Acupuncture – Electrostimulation – Herbal medicine – Magnets – Dietary supplements – Imagery – Spiritual healing Limited evidence for most modalities Evidence is encouraging and warrants further study for: – Cannabis extract – Carnitine – Electrostimulation – Magnets Ang CD et al. Cochrane Database Syst Rev 2008; 3:CD004573; Pittler MH, Ernst E. Clin J Pain 2008; 24(8): The effectiveness of B vitamins in reducing chronic neuropathic pain has not been established

SNRI = serotonin norepinephrine reuptake inhibitor; TCA = tricyclic antidepressant Thai Association for the Study of Pain. Clinical Practice Guidelines for Neuropathic Pain. Available at: Accessed: October 10, What is the most effective way to relieve symptoms of allodynia? Medications Clinical presentation of neuropathic pain BurningLancinatingHyperalgesiaAllodynia Parethesia, dysesthesia TCAAmitriptyline +++/-++ + SNRIVenlafaxine ++/-++ Duloxetine +++/-++++/- Na + channel blockers: Carbamazepine +/ Oxcarbazepine +/ Ca 2+ channel α 2 δ ligands: Gabapentin +++/-++ + Pregabalin +++/-++ + Opioids:Tramadol ++/-+++ Morphine +/- Drug Selection According to Clinical Presentation

Why are nsNSAIDs/coxibs not effetive in neuropathic pain? Coxib = COX-2-specific inhibitor; NSAID = non-steroidal anti-inflammatory drug nsNSAID = non-specific non-steroidal anti-inflammatory drug Gastrosource. Non-steroidal Anti-inflammatory Drug (NSAID)-Associated Upper Gastrointestinal Side-Effects. Available at: Accessed: December 4, 2010; Vane JR, Botting RM. Inflamm Res 1995;44(1):1-10. COX-1 (constitutive) COX-2 (induced by inflammatory stimuli) Prostaglandins Gastrointestinal cytoprotection, platelet activity Prostaglandins Inflammation, pain, fever nsNSAIDs Coxibs Pain relief BLOCK Arachidonic acid

Mechanisms of Neuropathic Pain Nerve lesion/disease Spinal cord Nociceptive afferent fiber Gilron I et al. CMAJ 2006; 175(3):265-75; Jarvis MF, Boyce-Rustay JM. Curr Pharm Des 2009; 15(15):1711-6; Scholz J, Woolf CJ. Nat Neurosci 2002; 5(Suppl): Loss of inhibitory control Central sensitization Ectopic discharge Peripheral sensitization Brain Nerve lesion/disease Descending modulation Central sensitization Nerve lesion/disease There is no target for nsNSAIDs/coxibs to act on in neuropathic pain

What about surgery for neuropathic pain? Surgery may be useful in only very select cases: – Refractory cases of trigeminal neuralgia – Spinal cord stimulation for patients with failed back surgery syndrome and treatment-resistant complex regional pain syndrome Neurostimulation may be useful in cases of refractory neuropathic pain, though results appear to be variable Surgery is not generally recommended for radiculopathy Pollock BE. Curr Neurol Neurosci Rep 2012; 12(2):125-31; Jacobs WC et al. Eur Spine J 2011; 20(4):513-22; Mailis A, Taenzer P. Res Manag 2012; 17(3):150-8; Nizard J et al. Discov Med 2012; 14(77):

When should combination therapy be used for neuropathic pain? Initiate treatment with one or more first-line treatments: α 2 δ ligands (gabapentin, pregabalin) SNRIs (duloxetine, venlafaxine) *Use tertiary amine TCAs such as amitiptyline only if secondary amine TCAs are unavailable Note: there is insufficient support for the use of nsNSAIDs in neuropathic pain nsNSAID = non-specific non-steroidal anti-inflammatory drug; SNRI = serotonin-norepinephrine reuptake inhibitor; TCA = tricyclic antidepressant Dworkin RH et al. Mayo Clin Proc 2010 ; 85(3 Suppl):S3-14; Freynhagen R, Bennett MI. BMJ 2009; 339:b3002. TCAs* (nortriptyline, desipramine) Topical lidocaine (for localized peripheral pain) If there is partial pain relief, add another first-line medication If there is no or inadequate pain relief, switch to another first-line medication If first-line medications alone and in combination fail, consider second-line medications (opioids, tramadol) or third-line medications (bupropion, citalopram, paroxetine, carbamazepine, lamotrigine, oxcarbazepine, topiramate, valproic acid, topical capsaicin, dextromethorphan, memantine, mexiletine) or referral to pain specialist STEP 1 STEP 2 STEP 3

How should medications for neuropathic pain be titrated? MedicationStarting doseTitrationMax. dosageTrial duration α 2 δ ligands Gabapentin100–300 mg at bedtime or tid ↑ by 100–300 mg tid every 1–7 days 3600 mg/day3–8 weeks + 2 weeks at max. dose Pregabalin50 mg tid or 75 mg bid↑ to 300 mg/day after 3–7 days, then by 150 mg/day every 3–7 days 600 mg/day4 weeks SNRIs Duloxetine30 mg qd↑ to 60 mg qd after 1 week 60 mg bid4 weeks Venlafaxine37.5 mg qd↑ by 75 mg each week 225 mg/day4–6 weeks TCAs (desipramine, nortriptyline 25 mg at bedtime↑ by 25 mg/day every 3–7 days 150 mg/day6–8 weeks, with ≥2 weeks at max. tolerated dosage Topical lidocaine Max. 3 5% patches/day for 12 h max. None neededMax. 3 patches/day for 12–18 h max. 3 weeks SNRI = serotonin-norepinephrine reuptake inhibitor; TCA = tricyclic antidepressant Dworkin RH et al. Mayo Clin Proc 2010; 85(3 Suppl):S3-14.

Can you use α 2 δ ligands with CCBs? Yes! – Unlike CCBs, α 2 δ ligands do not completely block the calcium channel, resulting in virtually no change in systemic blood pressure or coronary blood flow changes CCB = calcium channel blocker Lowther C. Pharmacotherapy Update 2005; 8(5):1-6.

Can you stop α 2 δ ligands “cold turkey”? No! Medications should be tapered gradually over at least one week Abrupt discontinuation may result in adverse effects, such as insomnia, nausea, headache, and diarrhea Thomas JL, Walker RR. Am Fam Physician 2006; 74(12):